These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity. Bennett NK; Chmielowski R; Abdelhamid DS; Faig JJ; Francis N; Baum J; Pang ZP; Uhrich KE; Moghe PV Biomaterials; 2016 Dec; 111():179-189. PubMed ID: 27736702 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Masaracchia C; König A; Valiente-Gabioud AA; Peralta P; Favretto F; Strohäker T; Lázaro DF; Zweckstetter M; Fernandez CO; Outeiro TF Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140298. PubMed ID: 31676453 [TBL] [Abstract][Full Text] [Related]
8. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity. Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248 [TBL] [Abstract][Full Text] [Related]
9. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease. Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782 [TBL] [Abstract][Full Text] [Related]
10. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease. Gonçalves SA; Outeiro TF Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512 [TBL] [Abstract][Full Text] [Related]
16. Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture. Myöhänen TT; Norrbacka S; Savolainen MH Neurosci Lett; 2017 Jan; 636():83-89. PubMed ID: 27818354 [TBL] [Abstract][Full Text] [Related]
17. Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight. Al-Azzani M; König A; Outeiro TF Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204823 [TBL] [Abstract][Full Text] [Related]
18. Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast. Brás IC; Tenreiro S; Silva AM; Outeiro TF FEMS Yeast Res; 2018 Dec; 18(8):. PubMed ID: 30277516 [TBL] [Abstract][Full Text] [Related]
19. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002 [TBL] [Abstract][Full Text] [Related]
20. Toxic Metamorphosis-How Changes from Lysosomal to Cytosolic pH Modify the Alpha-Synuclein Aggregation Pattern. Eymsh B; Drobny A; Heyn TR; Xiang W; Lucius R; Schwarz K; Keppler JK; Zunke F; Arnold P Biomacromolecules; 2020 Dec; 21(12):4673-4684. PubMed ID: 32986422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]